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Rhodiola is a genus of medicinal plants that originated in Asia and Europe and are used
traditionally as adaptogens, antidepressants, and anti-inflammatory remedies. Rhodiola
plants are rich in polyphenols, and salidroside and tyrosol are the primary bioactive
marker compounds in the standardized extracts of Rhodiola rosea. This review article
summarizes the bioactivities, including adaptogenic, antifatigue, antidepressant, antioxi-
dant, anti-inflammatory, antinoception, and anticancer activities, and the modulation of
immune function of Rhodiola plants and its two constituents, as well as their potential to
prevent cardiovascular, neuronal, liver, and skin disorders.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.
 
Open access under CC BY-NC-ND license.1. Introduction
The genus Rhodiola (Hong Jing Tian; Crassulaceae) consists of
more than 200 species, of which approximately 20, including
Rhodiola rosea, Rhodiola alterna, Rhodiola brevipetiolata, Rhodiola
crenulata, Rhodiola kirilowi, Rhodiola quadrifida, Rhodiola sachali-
nensis, and Rhodiola sacra, are used as traditional medicines in
Asia [1]. These plants growmainly in theHimalayan belt, Tibet,
China, and Mongolia, but are also cultivated in Europe and
North America and are available on the market as dietary
supplements [2,3]. Rhodiola plants extracts are traditionally
used in tonics and adaptogen, antidepressant, and anti-
inflammatory drugs [2,4]. The most widely known is Rhodiola
rosea, which is also called the “golden root” or “roseroot.” Theeceutics, China Medical
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ministration, Taiwan. Publpharmacological effects of Rhodiola rosea, including its role in
increasing longevity, stimulating the central nervous system,
and elevating work performance as well as its cardio-, neuro-,
and hepatoprotective effects and immunotropic, antiviral,
anti-inﬂammatory, and antibacterial activities, have been
studied extensively [1,5]. Rhodiola rosea has been used for a long
time in Eastern Europe and Asia to enhance physical and
mental performance. It is also used in Eastern Europe and Asia
as a traditional medicine to stimulate the nervous system,
alleviate depression and fatigue, enhance work performance,
andpreventhigh-altitude sickness,mountainmalhypoxia, and
anoxia [6], and in Russia and Mongolia for treating long-term
illness and weakness caused by infection [7]. In addition, Rho-
diola rosea has been proven to have cardiovascular protection
effects [8,9]. In recent years, the root extracts of Rhodiola roseaUniversity, 91 Hsueh-Shih Road, Taichung 404, Taiwan.
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pharmaceutical preparations offered worldwide [10].
Rhodiola plants contain polyphenols such as ﬂavonoids,
proanthocyanidines, tyrosol, and cinnamyl alcohol, as well as
glycosides, organic acids, essential oils, sugars, fats, alcohols,
and proteins [5]. The polyphenol content of Rhodiola rosea is
approximately 41.4 ± 3.41% [11]. Rosavin (such as rosavin,
rosarin, rhodionin, rhodiosin, and rosin), cinnamyl alcohol,
salidroside (Fig. 1B), and tyrosol (Fig. 1A) are the major com-
ponents of Rhodiola plants [12e18]. Salidroside and its agly-
cone, tyrosol, are the major compounds of Rhodiola rosea, and
the content of the two compounds are often used as a criterion
in evaluating the quality of crude drugs of Rhodiola rosea [19].
This review article presents an overview of the bioactivities
of Rhodiola plants and their major components.2. Adaptogenic and antifatigue activity
Adaptogens are substances that enable the normalization of
physiologic responses to various stressors, enhances work
performance, and increases the stress tolerance of the body
[20,21]. Researchers have categorized Rhodiola rosea as an
adaptogen because of its observed ability to increase resistance
to various chemical, biological, and physical stressors
[4,6,22,23] and its performance-enhancing effect in humans
[24]. A study reported that repeated administration of Rhodiola
rosea extract, SHR-5, exerts an antifatigue effect that increases
mental performance, particularly the ability to concentrate,
and reduces cortisol response to awakening stress in patients
with burnout and fatigue syndrome [25]. The adaptogenic and
central nervous system activities of Rhodiola rosea may be
attributable to its influence on the levels and activity of
monoamines and opioid peptides such as beta-endorphins [3].
Administering 100 mg/kg of an aqueous extract of Rhodiola
imbricata provided maximum resistance to cold-hypoxia-
restraint stress-induced hypothermia and quickened recov-
ery from the stressor [26]. In addition, the aqueous extract of
Rhodiola imbricata exhibited dose-dependent adaptogenic ac-
tivity [27]. Research indicated that Rhodiola extracts have greatFig. 1 e (A) The structure of tyrosol; (B) the structure of
salidroside.utility in treating asthenic conditions which develop after
intense physical or intellectual strain, including a decline in
work performance, sleep difficulties, poor appetite, irritability,
hypertension, headaches, and fatigue [27].
Intense exercise increases oxygen consumption and cau-
ses oxidative stress as a result of increased reactive oxygen
species (ROS) production [28]. Exogenous antioxidants may
prevent oxidative damage because they scavenge ROS gener-
ated during exercise [29e32]. Salidroside was reported to
elevate exercise tolerance and increase the liver glycogen
levels of rats after exhaustive exercise such as swimming [29].
In addition, salidroside reduced malondialdehyde (MDA)
levels and enhanced the activity of antioxidant enzymes [such
as catalase, superoxide dismutase (SOD), and glutathione
peroxide] in the liver tissue of Sprague-Dawley (SD) rats [29].
The above mentioned studies suggested that Rhodiola
plants elevate work performance and resistance to stress, and
that salidroside is effective in preventing oxidative stress
following exhaustive exercise.3. Elongation of lifespan and anti-aging
activity
Rhodiola markedly increased the lifespan of Drosophila mela-
nogaster, possibly by increasing the resistance of organs to
stress and alleviating oxidative stress [33]. Salidroside
considerably reversed senescence-like phenotypes in an
oxidant-challengedmodel, altering themorphology, cell cycle,
SA-b-gal staining, and DNA damage as well as the expression
of related molecules such as p53, p21, and p16 in the 2BS cell
line (human fetal lung fibroblasts). Furthermore, the protec-
tion occurred in a dose-dependent manner [34]. In addition,
salidroside blocked D-galactose-induced increases in serum
advanced glycation endproduct levels in C57BL/6J mice [35]. It
reversed D-galactose-induced aging effects in neural and im-
mune systems, improved motor activity, increased memory
latency time, and enhanced lymphocyte mitogenesis and
interleukin-2 (IL-2) production [35]. Furthermore, salidroside
reduced the elevated expression of glial fibrillary acidic pro-
tein and neurotrophin-3 in a mouse model of aging [35].
Accordingly, Rhodiola plant extracts and salidroside are
potential agents for retarding aging and attenuating age-
related diseases in humans and animals.4. Antioxidative activity
ROS such as superoxide anions (O2
), hydroxyl radicals (OH),
and hydrogen peroxide (H2O2) can cause oxidative stress in
cellular DNA, protein, and lipids, resulting in numerous
disorders and diseases, such as aging-related diseases,
cancer, cardiovascular diseases, diabetes mellitus (DM), and
various neurodegenerative diseases [32,36,37]. In addition, a
Rhodiola plant extract exhibited antioxidant activity and
reduced lipid peroxidation in SD rats [38]. Rhodiola rosea
showed singlet oxygen scavenging, H2O2 scavenging, hypo-
chlorite scavenging, ferric reducing, ferrous chelating, and
protein thiol protection activities [11]. Rhodiola rosea extract
reduced glutathione levels, glyceraldehyde-3-phosphate
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substances levels in cultured human keratinocytes exposed
to various oxidative insults such as Fe2þ/ascorbate, Fe2þ/
H2O2, and tert-butyl-hydroperoxide insults [39]. In addition,
Rhodiola rosea extract inhibited the production of intracel-
lular ROS and increased the activity of antioxidant enzymes
such as catalase, SOD, glutathione peroxidase, and gluta-
thione reductase. Rhodiola rosea extract also increased in a
time- and dose-dependent manner the activity of trans-
plasma membrane oxidoreductase according to an indirect
evaluation of the intracellular redox status in keratinocytes
[39]. Rhodiola rosea extract and salidroside protected human
cortical neurons from oxidative stress and prevented
glutamate-induced cell apoptosis in a human cortical cell
line (HCN 1-A) [40].
Aqueous and alcoholic extracts of Rhodiola rhizomes were
observed to inhibit apoptosis and tert-butyl hydroperoxide
(tert-BHP)-induced free radical production and to restore the
antioxidant levels of U-937 human macrophages [41]. They
also inhibited tert-BHP-induced decreases in mitochondrial
transmembrane potential, significantly lowered the percent-
age of early and late apoptotic cells, and inhibited DNA single-
strand breaks induced by tert-BHP [41].
Rhodiola rosea supplementation can protect human
osteosarcoma-derived 143B cells or human fibroblast cell line
IMR-90 from ultraviolet light, paraquat, and H2O2 [42]. How-
ever, Rhodiola rosea did not alter the levels of the major anti-
oxidant defenses, nor did it markedly activate the antioxidant
response element or modulate heme-oxygenase-1 expression
levels at relevant concentrations [42].
Water and methanol extracts of Rhodiola sacra exhibit
active oxygen scavenging activities such as O2
 radical scav-
enging [43]. Oligomeric proanthocyanidin from Rhodiola rosea
(OPCRR) exhibited free-radical-scavenging activities such as
the scavenging of 1,1-diphenyl-2-picrylhydrazyl (DPPH), OH,
and O2
 [44]. In addition, OPCRR significantly enhanced the
oxidative stress defense system, including SOD and gluta-
thione peroxidase activities, and reduced the MDA content in
the serum, heart, liver, and brain tissue of mice [44]. These
results suggest that OPCRR has great potential to be a natural
antioxidant because of its antioxidant activities in vitro and
in vivo [44].
Salidroside reduced hydrogen-peroxide-induced intracel-
lular ROS production in human erythrocytes. In addition,
salidroside increased cell survival significantly and prevented
human erythrocytes from undergoing eryptosis or eryth-
roptosis mediated by H2O2 [45]. The protection activity of
salidroside may rise in a dose-dependent manner through its
antioxidative activity and the inhibition of caspase-3 activa-
tion and stress-induced intracellular Ca2þ production [45].
Salidroside is a protective agent against oxidative stress in
human erythrocytes and may be a suitable adaptogen for
enhancing the resistance of the body to stress and fatigue.
Like salidroside, Rhodiola rosea’s aglycone, tyrosol, has
various biological properties, including antioxidative, cancer
preventive, and anti-inﬂammatory properties [46]. Tyrosol
exhibits antioxidant activity, scavenges DPPH free radicals,
and has an IC50 of 4.7 mg/mL [47].
Rhodiola extract, salidroside, and tyrosol may prevent
oxidative-stress-related disorders.5. Anti-inflammatory activity
Studies have reported that the tincture extract of Rhodiola
rosea exhibits anti-inflammatory activity. In the plethys-
mometer test, orally administering Rhodiola rosea extract
(50 mg/kg body weight and 100 mg/kg body weight) signifi-
cantly reduced carrageenan-induced paw edema in Wistar
rats [48]. The extract (250 mg/kg body weight) inhibited
carrageenan-induced paw edema, formaldehyde-induced
arthritis, and nystatin-induced paw edema in a rat model in
a dose-dependent manner [1].
Rhodiola aqueous extract treatment of human peripheral
blood mononuclear cells (PBMCs) increased the production of
IL-6 and tumor necrosis factor-alpha (TNF-a) through phos-
phorylated IkB and the transcription factor NF-kB, showing
that this treatment has immunostimulatory potential [49]. The
treatment also increased the synergistic production of nitric
oxide (NO) and lipopolysaccharide (LPS) in RAW 264.7 cells.
Rhodiola extract at 250 mg/mL increased p-IkB expression and
activated the nuclear translocation of NF-kB in human PBMCs.
The results of the mentioned study suggest that Rhodiola acti-
vated proinflammatory mediators through the phosphoryla-
tion of inhibitory kB and the transcription factor NF-kB [49].
The tincture extract from Rhodiola rosea inhibited the ac-
tivities of enzymes relating to inflammation, including
cyclooxygenase-1 (COX-1), COX-2, and phospholipase A2
(PLA2) in an in vitro study [1]. The inhibition of nystatin-
induced edema and PLA2 suggested that membrane stabili-
zation is the most probable mechanism of the extract’s anti-
inflammatory action [1].
A Rhodiola rosea extract inhibited inflammatory C-reactive
protein and creatinine kinase expression in the blood levels of
healthy untrained volunteers after exhausting exercise [50],
indicating that the extract has an anti-inflammatory effect
and protects muscle tissue during exercise.
Rhodiola crenulata increased the survival rates of adult flies
and the expression of antimicrobial peptide genes after
pathogen or toxic compound ingestion. Moreover, decreased
levels of ROS and epithelial cell death were associated with
improvements in intestinal morphology in Drosophila mela-
nogaster [51]. Rhodiola crenulata extract may prevent inflam-
matory diseases of the intestine [51].
Salidroside attenuated D-galactosamine (700 mg/kg)-
induced and LPS (10 mg/kg)-induced increases in the levels of
TNF-a and serum nitric oxide in mouse liver tissue in a dose-
dependent manner [52]. Salidroside significantly attenuated
TNF-a, IL-1b, and IL-6 production in serum from mice chal-
lenged with LPS [53]. In a murine model of endotoxemia, mice
were treated with salidroside before or after LPS challenge,
and salidroside significantly increased the likelihood of sur-
vival [53]. Salidroside downregulated LPS-induced nuclear
transcription factor-B (NF-B) DNA-binding activation and
extracellular signal-related kinase (ERK)/Mitogen-activated
protein kinases (MAPK) signal transduction pathway produc-
tion in RAW 264.7 macrophages [53]. The results of this study
indicated that salidrosidemodulated early cytokine responses
by blocking NF-B and ERK/MAPK activation and increased
mouse survival. These effects of salidroside may be useful in
treating inflammation-mediated endotoxemia [53]. In
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in mice [54]. Pretreatment with a single 120 mg/kg dose of
salidroside prior to the administration of intratracheal LPS
induced mouse myeloperoxidase activity in lung tissue and
reduced the protein concentration and the total number of
cells, neutrophils, and macrophages in the bronchoalveolar
lavage fluid in BALB/c mice [54].
Salidroside administered 1 hour before LPS infusion
significantly attenuated inflammatory cell infiltration,
reduced the activity of myeloperoxidase in mammary tissue,
and reduced the concentration of TNF-a, IL-1b, and IL-6 in a
dose-dependent manner [55]. Salidroside also inhibited the
production of several inflammatory cytokines, including TNF-
a, IL-6, and IL-1b, and NF-kB DNA-binding activation after LPS
challenge [54]. These results indicated that salidroside exerts a
protective effect on LPS-induced acute lung injury in mice.
Another study reported that salidroside downregulated the
phosphorylation of LPS-induced NF-kB p65 and an inhibitor of
NF-kB a (IkBa) in the NF-kB signal pathway and suppressed the
phosphorylation of p38, ERK, and c-jun NH(2)-terminal kinase
(JNK) in MAPK signaling pathways [55,56]. Salidroside is an
effective suppressor of inflammation and may be a candidate
for the prophylaxis of mastitis.
Salidroside pretreatment reduced the ratio of concanavalin-
A-induced aspartate transaminase to alanine transaminase
(also called the aspartate-aminotransferase-to-alanine-
aminotransferase ratio) markedly and suppressed the secre-
tion of proinflammatory cytokines by downregulating the ac-
tivity of NF-kB [57]. Salidroside altered the distribution of CD4þ
and CD8þ T lymphocytes in the liver and spleen by regulating
CXCL-10 and reduced the severity of liver injuries [57].6. Antinociceptive effect
Studies have reported that Rhodiola extract exhibits analgesic
activity. The antinociceptive effect of Rhodiola extract was
evaluated using the hot-plate test, Randall-Selitto test, and
formalin test in male Wistar rats. In the hot-plate test, orally
administering Rhodiola rosea at 50 mg/kg and 100 mg/kg body
weight increased the latency reaction [48]. In the Randall-
Selitto test, Rhodiola rosea caused a significant increase in
pressure reaction at 50 mg/kg [48]. In the formalin test, Rho-
diola rosea significantly reduced the paw-licking time during
the first phase at 100 mg/kg [48]. The studies indicated that
Rhodiola rosea extract exhibited significant analgesic activity in
different pain models, inhibiting thermal pain, mechanical
hyperalgesia, and formalin-induced pain behavior.7. Immune system
Rhodiola aqueous extract significantly enhanced tetanus
toxoid-specific immunoglobulin levels in rats [58] and the
level of ovalbumin-induced antibody responses. Tetanus
toxoid and ovalbumin in combination with complete Freund's
adjuvant or Rhodiola aqueous extract were observed to evoke a
significant delayed-type hypersensitivity response [58]. Rho-
diola aqueous extract did not suppress the swelling responsein an adjuvant-induced arthritis model [58]. Rhodiola aqueous
extract exhibits adjuvant and immunopotentiating activity.
Rhodiola imbricata rhizome extract inhibited the prolifera-
tion of the human T-cell lymphoma cell line EL-4 and eryth-
roleukemic cell line HL-60 [59]. Furthermore, treating human
peripheral blood mononuclear cells (hPBMCs) with LPS and
Rhodiola imbricata extract suppressed regulated upon activa-
tion, normal T cell expressed and secreted production [59].
However, the number of TNF-a spots in Rhodiola imbricata-
rhizome-extract-treated hPBMCs increased. Rhodiola imbricata
extract upregulated TLR-4 mRNA expression in the spleno-
cytes of rats [59].
Aqueous and 50% hydroalcoholic extracts of Rhodiola
quadrifida stimulated granulocyte activity in vitro and
increased the response of lymphocytes to mitogens in mice
and rats [60]. The ability of parental strainmouse lymphocytes
to induce a local cutaneous graft-versus-host reaction in F1
hybrids was stimulated by the 50% hydroalcoholic extract [60].
In vitro aqueous and 50% hydroalcoholic Rhodiola kirilowii
extracts stimulated granulocyte activity and increased
lymphocyte response to mitogens, and, in vivo, they enhanced
the ability of lymphocytes derived from parental strain mice
fed Rhodiola kirilowii aqueous and hydroalcoholic extracts to
induce a local cutaneous graft-versus-host reaction in F1 hy-
brids [61]. The results of this study suggested that Rhodiola
kirilowii extract enhances cellular immunity [61].
In another study, the dietary intake of salidroside
increased the total number of T cells (CD3þ) and T helper cells
(CD4þ) in aged Wistar male rats (21 months old), and sali-
droside supplementation significantly increased the delayed-
type hypersensitivity response in aged rats and substantially
increased the production of anti-keyhole limpet hemocyanin
(anti-KLH) IgG, anti-KLH IgG 1, and anti-KLH IgG 2 a in aged
rats without disturbing immune homeostasis [62].
Intraperitoneally administering salidroside before an oval-
bumin challenge resulted in the significant inhibition of asth-
matic reactions [63]. Moreover, ovalbumin significantly
increased the activation of NFkB and p38 in lung tissue,
whereas salidroside markedly suppressed NF-kB translocation
and reduced the phosphorylation of p38 [63]. Salidroside
attenuated the expression of intercellular adhesionmolecule 1
and IL-6 bymodulating the activities of p38 and NF-kB in BEAS-
2B cells stimulated by proinflammatory cytokines [63].
These results indicate that Rhodiola plant extracts influence
immune modulation and salidroside prevents ovalbumin-
induced airway inflammation and airway hyper responsive-
ness, at least in part by downregulating NF-kB and p38 activ-
ities [63].8. Antidepression
Extracts of SHR-5 from Rhodiola rosea rhizomes alleviated
depressive symptoms in patients with mild or moderate
depression, yielding no severe side effects [20]. Orally
administering salidroside (20mg/kg and 40mg/kg) for 2 weeks
notably alleviated olfactory-bulbectomy-induced hyperactiv-
ity in an open-field test and reduced immobility time in a
forced swimming test [64]. Chronic treatment with salidroside
greatly reduced TNF-a and IL-1b levels in the hippocampus
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derived neurotrophic factor expression in the hippocampus
of rats. In addition, salidroside attenuated corticotropin-
releasing hormone expression in the hypothalamus and the
levels of serum corticosterone [64]. Salidroside significantly
reduced depression-like behavior in olfactory bulbectomized
rats; the mechanisms of this reduction might be associated
with the anti-inflammatory effects of and regulation of
hypothalamicepituitaryeadrenal axis activity by salidroside.9. Skin care and skin whitening
Studies have reported the potential for using Rhodiola rosea
extract in skin care andwound healing, and that Rhodiola rosea
extract modulates skin melanogenesis. Rhodiola rosea extract/
L-carnosine-associated compound (RCAC) treatment for sen-
sitive skin reduced transepidermal water loss in humans,
thereby improving skin barrier function [65]. RCAC treatment
also exhibited a positive subjective response in patients with
sensitive skin, promoted the release of proopiomelanocortin
peptides, and returned to normal levels the increased number
of neuropeptides and cytokines produced by keratinocytes
exposed to ultraviolet radiation [65].
Rhodiola imbricata-treated wounds healed more rapidly
than control group, and the plant extract promoted cellular
proliferation and collagen synthesis at the wound site in SD
rats [38]. Rhodiola imbricata extract increased DNA, protein,
hydroxyproline, and hexosamine expression in granulation
cells more than providoneeiodine ointment [38]. The extract
also exhibited antioxidant activity and reduced lipid peroxi-
dation. Thus, it exhibits wound healing activity.
Propionibacterium acnes, a Gram-positive bacterium, is crit-
ical in the pathogenesis of acne vulgaris [66]. Propionibacterium
acnes is capable of biofilm formation, and the decreased
antimicrobial susceptibility of biofilm-associated cells may
hamper the effective treatment of Propionibacterium acnes
infection. Rhodiola crenulata extract exhibited antibiofilm ac-
tivity against Propionibacterium acnes [66].
Melanin is responsible for skincolorandplaysamajor role in
the defense against harmful external factors such as ultraviolet
irradiation [67e70]. Tyrosinase is the rate-limiting step of tyro-
sine hydroxylation and is responsible for the critical steps of
melanogenesis [70,71]. The mechanisms of the action of skin
hypopigmenting agents are thought to bebased on the ability of
an agent to inhibit the activity of tyrosinase and, thus, down-
regulate melanin synthesis [70,72,73]. Studies have shown that
the acetone extract of Rhodiola rosea exhibits antityrosinase
activity [74] and that the hydroalcoholic extract of Rhodiola rosea
extract and its hydrolysate inhibited melanin synthesis and
tyrosinase activity in B16F0 cells (mouse melanoma cells) [75].
Rhodiola rosea extract also inhibited the gene and protein
expression of melanocortin 1 receptor (MC1R), inhibited c-AMP
responseelement bindingproteinphosphorylation, suppressed
the activation of AKT and glycogen synthase kinase-3 beta
(GSK3b), and inhibited the expression of microphthalmia-
associated transcription factor and tyrosinase-related protein
1 (TRP-1) [70,76,77]. The hydrolysate of Rhodiola rosea inhibited
the phosphorylation of CREB, activation of AKT and GSK3b, and
expression of MITF and tyrosinase.In one study, tyrosol and its glycoside, salidroside, exhibited
antimelanogenesis activity [78]. Treating B16F0 cells with tyro-
sol and salidroside reducedmelanin content and the inhibition
of tyrosinaseactivityand its expression [78].Tyrosol suppressed
a-MSH-inducedMC1RandTRP-1 expression, but salidrosidedid
not. Neither tyrosol nor salidroside affected MITF or TRP-2
expression. The compounds exhibited metal-coordinating in-
teractions with copper ions in molecular docking with tyrosi-
nase [78]. Salidroside significantly inhibited tyrosinase activity
inB16F0cells at 1000mMandmelanincontent at 1001000mMin
a dose-dependent manner [79]. Salidroside inhibited UVB-
induced hyperpigmentation in brown guinea pig skin by
reducing thenumberofDOPA-positivemelanocytes in thebasal
layer of the epidermis and reducing tyrosinase activity and
melanin synthesis in melanocytes [79]. Rhodiola rosea extract,
salidroside, and tyrosolmaybeeffective skin-whiteningagents;
Table 1 summarizes their effects on skin.10. Protection against neuron and central
neuron system disorders
A titolated extract from Rhodiola rosea and salidroside pro-
tected human cortical cells (HCN 1-A) from oxidative stressors
such as H2O2 and glutamate-induced cell apoptosis [40]. Pre-
treatment with Rhodiola rosea extract significantly increased
cell survival and prevented plasma membrane damage and
morphological disruption caused by glutamate or H2O2, indi-
cating that Rhodiola rosea extract protects neurons from
oxidative-stress-induced disorders [40]. In addition, Rhodiola
rosea extract significantly reduced oxidative-stress-induced
elevation of intracellular free Ca2þ concentrations [40].
Significant improvement in long-term memory was
observed after 10 days of treatment with 0.1 mL of Rhodiola
rosea extract [6]. However, in another study, Rhodiola rosea
exhibited cytotoxic effects at 100 mg/mL in cultured primary
cortical neurons [80]. Rhodiola rosea extracts exhibited anti-
oxidant capacity but did not exhibit neuroprotective effects in
primary cortical neurons [80].
Salidroside suppressed the LPS-induced expression of
iNOS and cytokines in BV2 cells in a concentration-dependent
manner [81]. Orally administering Rhodiola rosea crude extract
(500 mg/kg) suppressed the expression of the proin-
flammatory factors iNOS, IL-1b, and TNF-a in the kidney and
prefrontal cortex of the brain in mice [81]. L-Glutamate treat-
ment increased the levels of phosphorylated MAPK, p-JNK,
and p-p38 [81]. These results indicate that Rhodiola rosea may
have therapeutic potential for treating inflammation and
neurodegenerative disease [81].
Oxidative stress plays a crucial role in Parkinson's disease
and other neurodegenerative disorders. Salidroside has a
neuroprotective effect in cortical neurons because of its
antioxidant activity and ability to stabilize cellular Ca2þ ho-
meostasis [40]. Incubating PC12 cells with salidroside prior to
MPPþ exposure significantly reduced cell apoptosis and
attenuated the collapse of the mitochondrial membrane po-
tential [82]. Furthermore, salidroside inhibited MPPþ-induced
NO increases, the overexpression of nNOS and iNOS, and the
accumulation of ROS and intracellular free Ca2þ[82]. Salidro-
side inhibited ROS and NO production, protecting PC12 cells
Table 1 e The activities of Rhodiola plants and its active constituents on skin disorders.
Plants/constituents Models Results References
Rhodiola rosea B16F0 cells 1 Suppressed melanin synthesis and
tyrosinase activity
2 Inhibited TRP-1 and tyrosinase expression
3 Inhibited MC1R/ CREB/ GSK3b/MITF
[74,75]
Rhodiola rosea extract/
L-carnosine-associated compound
Human skin 1 Reduced transepidermal water loss (TEWL)
2 Elevated the skin barrier function
3 Positive subjective response
[65]
Rhodiola rosea extract/
L-carnosine-associated compound
Keratinocytes 1 Promoted the release of proopiomelanocortin
peptides
2 Restored to normal the increased levels
of neuropeptides and cytokines
[65]
Rhodiola imbricata SD rats 1 Promoted wound healing
2 Promoted cellular proliferation
3 Increased collagen synthesis
4 Increased the DNA, protein, hydroxyprolin,
and hexosamine in granulation cells
5 Antioxidant and decrease lipid peroxidation
[38]
Rhodiola crenulata extract Propionibacterium
acnes
antibiofilm activity against Propionibacterium acnes [66]
Salidroside B16F0 cells Suppressed melanin synthesis and tyrosinase
activity, but no effect on the expression of MC1R,
MITF, TRP-1, or TRP-2
[74,78,79]
Tyrosol B16F0 cells 1 Suppression of melanin synthesis and tyrosinase activity
2 Suppressed the expression of MC1R and TRP-1,
but not TRP-2 and MITF
[78]
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PC12 cells are mediated by the inhibition of ROS generation
and the NO pathway [82]. In addition, salidroside pretreat-
ment protected dopaminergic neurons against MPTP/MPPþ-
induced toxicity in a dose-dependent manner [83]. The
mechanisms of this protection included salidroside reducing
the production of ROS and NO, regulating the ratio of Bcl-2/
Bax, reducing cytochrome-c and Smac release, inhibiting
caspase-3, caspas-6, and caspas-9 activation, and reducing a-
synuclein aggregation [83].
Pretreatment with salidroside markedly attenuated H2O2-
induced cell viability loss and apoptotic cell death in a dose-
dependent manner in human neuroblastoma SH-SY5Y cells
[84]. Salidroside protected neuron cells from oxidative stress
by inducing several antioxidant enzymes such as thioredoxin,
heme oxygenase-1, and peroxiredoxin-I and downregulating
the proapoptotic gene Bax and upregulating the antiapoptotic
genes Bcl-2 and Bcl-XL [84]. Furthermore, salidroside dose-
dependently restored H2O2-induced loss of mitochondrial
membrane potential and elevated intracellular calcium levels
[84]. Salidroside alleviated hydroxyl-peroxide-induced cell
viability loss and apoptotic cell death in a dose-dependent
manner in cultured nerve-growth-factor-differentiated PC12
cells [85]. The neuroprotective effects of salidroside might be
modulated by the ERK signaling pathway, particularly at the
level of or upstream from caspase-3 [85]. In addition, salidro-
side (100 mM) significantly reducedhydroxyl-peroxide-induced
apoptosis and necrosis and markedly attenuated oxidative
insult caused by hydroxyl peroxide exposure in cultured rat
cortical neurons [86]. Salidroside prevented cerebral ischemic
injury induced by middle cerebral artery occlusion and
reperfusion in SD rats. Furthermore, there were more normal
neurons and cells in the hippocampus after salidroside treat-
ment [86]. These results suggest that salidroside has protectiveeffects against oxidative-stress-induced cell apoptosis and is
thus a potential therapeutic agent for treating or preventing
neurodegenerative diseases involving oxidative stress.
Salidroside reduced neuronal death and behavioral
dysfunction mediated by polyglutamine expressed in ASH
neurons in transgenic Caenorhabditis elegans [87]. Salidroside’s
antioxidative capability, but not its direct inhibition of poly-
glutamine aggregation, may contribute to neuron protection
[87].
Rhodiola plant extracts and salidroside prevented neural
disorders such as Parkinson's disease and other neurodegen-
erative disorders. Table 2 lists studies of the effects of these
agents on neurons.11. Liver protection
The methanolic extract from the roots of Rhodiola sachalinensis
exhibited a protective effect on D-galactosamine-induced
cytotoxicity in primary cultured mouse hepatocytes [88]. In
addition, the principal constituents, sachalosides III and IV,
rhodiosin, and transcaffeic acid, exhibited hepatoprotective
effects [88].
Salidroside attenuated D-galactosamine- and LPS-induced
acute increases in serum aspartate aminotransferase and
alanine aminotransferase activities and in levels of TNF-a and
serum NO in a dose-dependent manner [52]. It restored
depleted hepatic glutathione, SOD, catalase, and glutathione
peroxidase activities, reduced MDA levels, and considerably
reduced histopathological changes in liver tissue [52]. In
addition, salidroside reduced the size of necrotic regions,
caspase-3 expression, and hypoxia-inducible factor (HIF)-1a in
liver tissue in mice [52]. The hepatoprotective mechanism of
salidroside may be related to antioxidant activity and the
Table 2 e The activities of Rhodiola plants and its active constituents on neuron system.
Plants/
constituents
Models Results References
Rhodiola rosea Human cortical cell
line (HCN 1-A)
1 Against oxidative stressor
2 Increased cell survival
3 Prevented the plasma membrane damage
[40]
Rhodiola rosea Rats improvement of the long-term memory [6]
Salidroside Transgenic Caenorhabditis
elegans models
1 Decreased ROS levels
2 Decreased paraquat-induced mortality
3 Increased antioxidant enzyme activities
4 Reduced lipid peroxidation
5 Reduced neuronal death and behavioral dysfunction
mediated by polyQ expressed in ASH neurons
[87]
Salidroside PC12 cells 1 Protected PC12 cells against MPPþ-induced apoptosis
2 Rescued MPPþ-induced changes in nuclear morphology
3 Attenuated the MPPþ-induced decrease in mitochondrial
membrane potential
4 Inhibited MPPþ-induced NO increase
[82]
Salidroside PC12 cells 1 Protected NGF-differentiated PC12 cells against H2O2-induced
neurotoxicity and apoptosis
2 Activated ERK phosphorylation
3 Antagonized H2O2-induced increase in cleaved caspase-3 protein
expression in a dose-dependent manner
[85]
Salidroside PC12 cells
C57BL/6 mice
1 Exerted a protective effect against MPPþ-induced cytotoxicity in PC12 cells
2 Reduced the MPPþ-induced rate of apoptosis in PC12 cells
3 Counteracted the decrease in the Bcl-2/Bax ratio and the expression of
the proteins induced by MPPþ in a dose-dependent manner in PC12 cells
4 Decreased the expression of Bcl-2, Bax, Cyt-c, Smac, caspase-3,
caspase-6, and caspase-9 in C57BL/6 mice
[83]
Salidroside Human neuroblastoma
SH-SY5Y cells
1 Prevented SH-SY5Y cells against H2O2-induced cytotoxicity
2 Increased thioredoxin, heme oxygenase-1 and peroxiredoxin-I mRNA
expression decreased by H2O2
3 Protected SH-SY5Y cells against H2O2-induced apoptosis
4 Prevented H2O2-induced reduction of the mitochondrial membrane
potential
5 Inhibited H2O2 -induced Ca
2þ influx increase
[84]
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protected liver tissue from oxidative-stress-induced damage.12. Cardiovascular disease
Rhodiola rosea was observed to prevent stress-induced cardiac
damage [9]. The cardioprotective effects of Rhodiola rosea,
including a pronounced antiarrhythmic effect [9], the preven-
tion of reduced coronary ﬂow, and an increase in contractility
in the postischemic period, were observed in animals [89].
Rhodiola rosea was ascertained to prevent both stress-induced
catecholamine release and elevation of cAMP levels in the
myocardium [9]. Moreover, it lowered blood pressure [90] and
prevented stress-induced cardiac damage, indicating its crit-
ical role as a cardioprotective agent in animals [8].
The rhizome of Rhodiola kirilowii significantly increased the
expression of vonWillebrand factor in the infarct border zone
and noninfarct zone in the myocardium of rats [91]. The
expression of HIF-1a, HIF-1b, and vascular endothelial growth
factor (VEGF) mRNAs as well as HIF-1a and VEGF proteins was
significantly increased in a Rhodiola kirilowii group [91].
Salidroside exhibited activity similar to that of Rhodiola
kirilowii, increasing the expression of HIF-1a, HIF-1b, and VEGF
during ischemia and hypoxia [91]. In addition, salidrosideprotected human endothelial cells (EVC-304) from H2O2-
induced oxidative damage in a dose-dependent manner [92].
Salidroside inhibited the activation of caspase-3, caspase-9,
cleavage of poly(ADP-ribose)polymerase, and Bax induced by
endogenous H2O2 [92].
Salidroside and tyrosol dose-dependently inhibited nu-
clear condensation in H9c2 cells [93]. Furthermore, salidroside
and tyrosol, separately and in combination, significantly
reduced caspase-3 activity, cytochrome c release, and JNK
activation. The antiapoptotic effect of the combination was
markedly higher than that of salidroside and tyrosol alone
[93]. The inhibition of the JNK-signaling pathway is the key
mechanism for the cytoprotective effects of salidroside and
tyrosol in ischemia-reperfusion-induced apoptosis in H9c2
cells [93]. Rhodiola plants, salidroside, and tyrosol may facili-
tate preventing and treating oxidative stress in cardiovascular
and cerebrovascular diseases.13. DM
DM is associated with increased oxidative stress. Rats with
streptozotocin (STZ)-induced DM experienced heart failure
caused by increased PPARd expression. The ethanol extract of
Rhodiola increased PPARd expression and cardiac output in
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 3 ( 2 0 1 5 ) 3 5 9e3 6 9366STZ-diabetic rats [94]. Salidroside administered to mice daily
(50 mg/kg, 100 mg/kg, and 200 mg/kg for 28 days) was
demonstrated to cause hypoglycemic activity and have pro-
tective effects against DM-induced oxidative stress, including
significantly reduced fasting blood glucose, total cholesterol,
triglyceride, and MDA levels [95]. In addition, it increased
serum insulin, SOD, and glutathione peroxidase levels as well
as catalase activity in the liver in mice [95]. Therefore, Rhodiola
extracts and salidroside should be considered for use in
treating DM [95].14. Obesity and hyperlipidemia
Rhodiola rosea inhibited the activity of lipase in isolated mouse
plasma in vitro and in the mouse gastrointestinal tube in vivo
and can be used in treating or preventing lifestyle-related
diseases such as hyperlipidemia and exogenous obesity [14].
Rhodiola extracts dose-dependently increased SOD activity,
resulting in a reduced ROS level during adipogenesis [96].
Treatment with Rhodiola extract inhibited the activities of
proline dehydrogenase (PDH) and glucose-6-phosphate de-
hydrogenase (G6PDH) as well as lipid accumulation and ROS
production in 3T3-L1 preadipocytes [96]. In addition, SOD ac-
tivity in cells treated with Rhodiola extract increased signi-
ficantly during the differentiation of 3T3-L1 preadipocytes
[96]. The inhibition of PDH and G6PDH prevented the proline
oxidation required for critical ATP generation that is coupled
with the antioxidant enzyme response via the proline-
mediated pentose phosphate pathway, leading to the inhibi-
tion of adipogenesis [96]. The antiadipogenic effects of Rho-
diola extract may disrupt proline-mediated energy generation
and antioxidant enzyme response via the proline-mediated
pentose phosphate pathway, resulting in the suppression of
adipogenesis and lipid accumulation [96].
Tyrosol at 1.0 mg/mL significantly increased SOD activity
during the differentiation of 3T3-L1 preadipocytes [96]. In
addition, tyrosol inhibited the activities of PDH and G6PDH
and lipid accumulation [96]. Rhodiola extract and tyrosol may
be used to prevent obesity.15. Anticancer
Incubation with Rhodiola imbricata aqueous extract at 100 mg/
mL and 200 mg/mL for 72 hours significantly reduced the
proliferation of K-562 human erythroleukemic cells in a dose-
dependent manner but not the proliferation of normal human
peripheral blood lymphocytes or RAW-264.7 mouse macro-
phage cells [97]. In addition, Rhodiola imbricata aqueous extract
was observed to induce intracellular ROS in K-562 cells at
200 mg/mL and, thus, induce apoptosis [97]. Rhodiola imbricata
aqueous extract arrested the cell cycle progression of K562
and NK cells in the G2/M phase in early and late periods of
exposure [97].
Salidroside significantly reduced the proliferation of A549
human alveolar adenocarcinoma cells, inhibited cell cycle
arrest in the G0/G1 phase, and induced apoptosis in A549 cells
by reducing pp38 protein expression [98]. Salidroside inhibited
transforming growth factor-b-induced tumor invasion andsuppressed protein expression [98]. Salidroside inhibited
intracellular ROS formation in a dose-dependent manner in
A549 cells [98]. Another study reported that salidroside
significantly reduced tumor-induced angiogenesis in mice [2].16. Antivirus activity
Salidroside provided protection against coxsackievirus B3,
which causes viral myocarditis, in both in vitro and in vivo
experiments [99]. The IC50 of salidroside for coxsackievirus B3
is 39.0 ± 1.2 mg/L. Salidroside can modulate the mRNA
expression of interferon-g, IL-10, TNF-a, and IL-2 in coxsack-
ievirus B3. Salidroside increased lactic dehydrogenase,
aspartate transaminase, and creatine kinase activities in
infected BALB/c mouse serum [100]. Salidroside is a potential
agent for treating viral myocarditis [99].17. Conclusion
Rhodiola plants are commonly used in traditional medicines in
Asia and Europe. Studies have shown that the plants and their
two major constituents, salidroside and tyrosol, exhibit
adaptogenic, antifatigue, antidepressant, antioxidant, anti-
inflammatory, antinoception, and anticancer bioactivities,
modulate immune function, and prevent cardiovascular,
neuronal, liver, and skin disorders.Conflicts of interest
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